UnitedHealth Group Incorporated (NYSE:UNH) Shares Acquired by Astoria Portfolio Advisors LLC.

Astoria Portfolio Advisors LLC. boosted its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 8.0% during the first quarter, HoldingsChannel.com reports. The firm owned 3,116 shares of the healthcare conglomerate’s stock after purchasing an additional 230 shares during the period. UnitedHealth Group makes up approximately 0.6% of Astoria Portfolio Advisors LLC.’s holdings, making the stock its 28th largest holding. Astoria Portfolio Advisors LLC.’s holdings in UnitedHealth Group were worth $1,541,000 at the end of the most recent quarter.

Other hedge funds also recently bought and sold shares of the company. Richelieu Gestion SA purchased a new position in shares of UnitedHealth Group in the fourth quarter valued at approximately $26,000. CGC Financial Services LLC lifted its position in shares of UnitedHealth Group by 1,000.0% in the fourth quarter. CGC Financial Services LLC now owns 55 shares of the healthcare conglomerate’s stock valued at $29,000 after acquiring an additional 50 shares in the last quarter. True Wealth Design LLC purchased a new position in shares of UnitedHealth Group in the fourth quarter valued at approximately $31,000. LFA Lugano Financial Advisors SA lifted its position in shares of UnitedHealth Group by 148.1% in the fourth quarter. LFA Lugano Financial Advisors SA now owns 67 shares of the healthcare conglomerate’s stock valued at $35,000 after acquiring an additional 40 shares in the last quarter. Finally, Transcendent Capital Group LLC acquired a new stake in shares of UnitedHealth Group in the fourth quarter valued at approximately $40,000. Hedge funds and other institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Price Performance

Shares of NYSE:UNH opened at $509.26 on Friday. The business’s 50 day simple moving average is $498.34 and its 200-day simple moving average is $502.27. The firm has a market capitalization of $468.72 billion, a price-to-earnings ratio of 31.15, a price-to-earnings-growth ratio of 1.41 and a beta of 0.58. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.85 and a quick ratio of 0.85. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $554.70.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 EPS for the quarter, topping the consensus estimate of $6.63 by $0.28. The business had revenue of $99.80 billion for the quarter, compared to analyst estimates of $99.23 billion. UnitedHealth Group had a return on equity of 26.50% and a net margin of 4.05%. The company’s quarterly revenue was up 8.6% on a year-over-year basis. During the same quarter in the previous year, the company earned $6.26 EPS. As a group, equities analysts forecast that UnitedHealth Group Incorporated will post 27.57 earnings per share for the current fiscal year.

UnitedHealth Group Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, June 25th. Investors of record on Monday, June 17th were paid a $2.10 dividend. The ex-dividend date of this dividend was Monday, June 17th. This represents a $8.40 dividend on an annualized basis and a yield of 1.65%. This is a positive change from UnitedHealth Group’s previous quarterly dividend of $1.88. UnitedHealth Group’s dividend payout ratio is presently 51.34%.

Wall Street Analysts Forecast Growth

Several equities research analysts recently commented on the company. Deutsche Bank Aktiengesellschaft increased their price target on UnitedHealth Group from $545.00 to $562.00 and gave the company a “buy” rating in a report on Friday, April 19th. TD Cowen cut their price target on UnitedHealth Group from $607.00 to $546.00 and set a “buy” rating for the company in a report on Wednesday, April 10th. Truist Financial reissued a “buy” rating and set a $600.00 target price on shares of UnitedHealth Group in a research note on Wednesday, April 17th. Wells Fargo & Company lowered their price target on UnitedHealth Group from $600.00 to $525.00 and set an “overweight” rating for the company in a research report on Monday, April 8th. Finally, Barclays raised their price target on UnitedHealth Group from $534.00 to $560.00 and gave the stock an “overweight” rating in a research report on Wednesday, April 17th. Three research analysts have rated the stock with a hold rating, seventeen have given a buy rating and one has given a strong buy rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $579.74.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.